Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil

Different countries have adopted strategies for the early detection of SARS-CoV-2 since the declaration of community transmission by the World Health Organization (WHO) and timely diagnosis has been considered one of the major obstacles for surveillance and healthcare. Here, we report the increase o...

Descripción completa

Detalles Bibliográficos
Autores principales: Grotto, Rejane Maria Tommasini, Santos Lima, Rodrigo, de Almeida, Gabriel Berg, Ferreira, Claudia Pio, Guimarães, Raul Borges, Pronunciate, Micheli, Azevedo, Edmur, Catão, Rafael de Castro, Fortaleza, Carlos Magno Castelo Branco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
From the Field
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477464/
https://www.ncbi.nlm.nih.gov/pubmed/32807244
http://dx.doi.org/10.1017/S0950268820001818
Descripción
Sumario:Different countries have adopted strategies for the early detection of SARS-CoV-2 since the declaration of community transmission by the World Health Organization (WHO) and timely diagnosis has been considered one of the major obstacles for surveillance and healthcare. Here, we report the increase of the number of laboratories to COVID-19 diagnosis in Brazil. Our results demonstrate an increase and decentralisation of certified laboratories, which does not match the much higher increase in the number of COVID-19 cases. Also, it becomes clear that laboratories are irregularly distributed over the country, with a concentration in the most developed state, São Paulo.

Ejemplares similares